By Dr Samuel Seidu2018-11-09T12:16:00+00:00
Dr Samuel Seidu answers questions on the impact of type 2 diabetes on patients’ daily lives, differences between NICE and SIGN guidance, and key take-home messages for primary care.
This was an independent session organised by MGP without financial support or involvement from the pharmaceutical industry.
A new single source for tobacco guidance from NICE, covering promoting quitting, and treating tobacco dependence and tobacco-dependent pregnant women
This newly updated easy-to-use summary covers the recognition, referral, and investigation of people who may have cancer
A new summary of NICE’s CKS on dental abscesses, covering management in non-dental primary care settings
This session was supported by an educational grant from Mylan Ltd. Dr Glenis Scadding comments on the main presentations of rhinitis, its impact on patients’ daily lives, red flags for referral, and the main recommendations of the 2017 BSACI guideline
Dr Kevin Fernando answers questions on the impact of type 2 diabetes on patients’ daily lives, differences between NICE and SIGN guidance, and key take-home messages for primary care
Dr Matt Fay, Chair of Guidelines Live 2018, provides his thoughts on the programme from a primary care perspective, and summarises the meetings.
Site powered by Webvision Cloud